X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Unichem Lab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs UNICHEM LAB - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD UNICHEM LAB MERCK LTD/
UNICHEM LAB
 
P/E (TTM) x 25.3 22.6 112.0% View Chart
P/BV x 2.8 2.4 119.1% View Chart
Dividend Yield % 1.0 0.8 125.1%  

Financials

 MERCK LTD   UNICHEM LAB
EQUITY SHARE DATA
    MERCK LTD
Dec-16
UNICHEM LAB
Mar-16
MERCK LTD/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs1,060334 317.4%   
Low Rs623174 358.0%   
Sales per share (Unadj.) Rs632.4146.9 430.5%  
Earnings per share (Unadj.) Rs45.711.9 384.4%  
Cash flow per share (Unadj.) Rs62.316.2 385.0%  
Dividends per share (Unadj.) Rs11.002.00 550.0%  
Dividend yield (eoy) %1.30.8 166.0%  
Book value per share (Unadj.) Rs388.8105.1 369.9%  
Shares outstanding (eoy) m16.6090.84 18.3%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.31.7 77.0%   
Avg P/E ratio x18.421.4 86.2%  
P/CF ratio (eoy) x13.515.7 86.1%  
Price / Book Value ratio x2.22.4 89.6%  
Dividend payout %24.116.8 143.1%   
Avg Mkt Cap Rs m13,96923,073 60.5%   
No. of employees `0001.65.7 27.9%   
Total wages/salary Rs m1,4872,558 58.1%   
Avg. sales/employee Rs Th6,631.92,352.5 281.9%   
Avg. wages/employee Rs Th939.2450.9 208.3%   
Avg. net profit/employee Rs Th479.4190.4 251.7%   
INCOME DATA
Net Sales Rs m10,49813,346 78.7%  
Other income Rs m242192 126.3%   
Total revenues Rs m10,74113,538 79.3%   
Gross profit Rs m1,1351,639 69.3%  
Depreciation Rs m276390 70.6%   
Interest Rs m029 0.0%   
Profit before tax Rs m1,1021,412 78.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-4 0.0%   
Extraordinary Inc (Exp) Rs m0-35 0.0%   
Tax Rs m343293 117.3%   
Profit after tax Rs m7591,080 70.2%  
Gross profit margin %10.812.3 88.1%  
Effective tax rate %31.120.7 150.3%   
Net profit margin %7.28.1 89.3%  
BALANCE SHEET DATA
Current assets Rs m6,4105,979 107.2%   
Current liabilities Rs m8,8282,432 363.0%   
Net working cap to sales %-23.026.6 -86.7%  
Current ratio x0.72.5 29.5%  
Inventory Days Days5863 91.5%  
Debtors Days Days3860 63.6%  
Net fixed assets Rs m1,4066,403 22.0%   
Share capital Rs m166182 91.4%   
"Free" reserves Rs m6,2869,293 67.6%   
Net worth Rs m6,4559,548 67.6%   
Long term debt Rs m0230 0.0%   
Total assets Rs m8,82812,843 68.7%  
Interest coverage xNM50.0-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.21.0 114.4%   
Return on assets %8.68.6 99.5%  
Return on equity %11.811.3 103.9%  
Return on capital %17.114.3 119.1%  
Exports to sales %8.329.2 28.3%   
Imports to sales %21.06.3 331.7%   
Exports (fob) Rs m8693,900 22.3%   
Imports (cif) Rs m2,209847 260.9%   
Fx inflow Rs m9594,356 22.0%   
Fx outflow Rs m2,6121,162 224.7%   
Net fx Rs m-1,6533,194 -51.8%   
CASH FLOW
From Operations Rs m1,0701,119 95.6%  
From Investments Rs m-750-853 87.9%  
From Financial Activity Rs m-150-334 44.8%  
Net Cashflow Rs m171-68 -250.2%  

Share Holding

Indian Promoters % 0.0 50.1 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 15.1 120.5%  
FIIs % 1.0 3.0 33.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 31.7 91.8%  
Shareholders   28,591 20,176 141.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   TTK HEALTHCARE  SUVEN LIFE  STERLING BIOTECH  ELDER PHARMA  ALEMBIC LTD  

Compare MERCK LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Pharma Drug Approvals, Global Updates, Oil Prices, and Top Stocks in Action Today(Pre-Open)

Indian share markets snapped their losing streak seen during last week and closed their Wednesday session on a positive note.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Aug 16, 2017 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - JUBILANT LIFE SCIENCES COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS